Kansas City COVID Numbers Decline Despite Dire Variant Warnings

Bright side . . .

Here's what we're really impressed with . . . 

Nobody is hassling people who still chose to wear masks. Fact is, the pandemic and plain old cold & flu season remains a big deal for older residents and those with medical troubles.

Here's a bit of local data . . .

"Local health departments reported 1,090 new COVID-19 cases in the past week, down from 1,440 per week over the holiday break. That brings the metro’s seven-day average down to around 156 new cases per day, compared to around 206 per day the previous weeks."

Read more via www.TonysKansasCity.com links . . .

Case numbers and hospitalizations continue to fall in Kansas City despite new variant

COVID-19 case numbers and hospitalizations are down in the Kansas City area this week as the new XBB.1.5 variant continues to circulate in the metro and around the country. Experts have called this new sublineage the "grandchild" of the omicron variant.

New COVID Variants Are Masters at Escaping the Immune System

BA.5, BQ.1.1, and XBB? It's no wonder people are struggling to keep all the circulating variants of COVID-19 straight right now.

Why COVID’s XBB.1.5 ‘Kraken’ Variant Is So Contagious

A new, rapidly spreading variant of SARS-CoV-2, the virus that causes COVID, means a rise in new infections could be around the corner. And while it likely won't skirt immunity completely, the variant could dodge some of our defenses thanks to a mutational boost.

Federal Reserve Chair Jerome Powell tests positive for COVID-19

MoneyWatch Federal Reserve Chair Jerome Powell has tested positive for , the central bank announced Wednesday. Powell, 69, "is experiencing mild symptoms," the Fed said in a statement. "Following Centers for Disease Control and Prevention guidance, he is working remotely while isolating at home."

Covid Isn't Going Away. New Drugs Are Coming.

A Covid-19 vaccine that comes as a pill. A better version of 's Paxlovid. A monoclonal antibody that can survive the virus's mutations. Drug company pipelines remain occupied with Covid-19, even as even masks fall away and the pandemic fades into the background. At the annual healthcare investor conference hosted last week by J.P.

Developing . . .